Melatonin Tri-layer

Natural health product licensed in Canada

Other names: 3 Deep Sleep, Deep Sleep 3, Sleep Cycle, Sleep Deeply, Super Sleep 3, Super Sleep 3 Tri-layer
Licence holder: WN Pharmaceuticals Ltd
NPN or DIN-HM: 80119610
Status: Active licence
Licence date: 27 June 2022
Revision date: 8 October 2025
Form: Comprimé, couches multiples, libération prolongée
Route of administration: Orale
Application type: Générale (non traditionelle)

If this product were sold in France

Conditions légales
Valeriana officinalis L.: L'absence de valépotriates doit être prouvée par des rapports d'analyse. L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and source	Per dosage unit, according to the source	Maximum per day, adult
L-5-hydroxytryptophane	15 mg	Not calculated
Valeriana officinalis Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 80 mg Potency : 0.25 % Valerenic acid	20 mg	Not calculated
N-[2-(5-méthoxy-1H-indol-3-yl)éthyl]acétamide Source : Mélatonine	10 mg	Not calculated
L-théanine Source : L-Théanine	200 mg	Not calculated

Non-medicinal ingredients

Phosphate de dicalcium dihydraté, Silice, NA, Cellulose, Stéarate de magnésium, Hydroxypropylcellulose, Acide stéarique, Croscarmellose de sodium, Glycérine, chlorophylline de cuivre sodium

Recommended doses in Canada

Population	Age	Quantity per serving	Frequency
Adultes	minimum: 18 years	1 Comprimé	1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps increase the total sleep time (aspect of sleep quality) in people suffering from sleep restriction or altered sleep schedule (e.g. shift-work and jet lag). Helps (to) prevent and/or reduce the effects of jetlag/minimize jet lag (e.g. daytime fatigue, sleep disturbance) (for people/if travelling by plane easterly across two or more time zones/flying east over two or more time zones). Helps (to) re-set the body's sleep-wake cycle (aspect of the circadian rhythm). Helps (to) speed up/reduce the time it takes to fall asleep (sleep onset latency aspect of sleep quality) in people who fall asleep slowly/with delayed sleep phase disorder. Helps to temporarily promote relaxation. (Used as a) sleep aid (to help promote sleep).

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.